BSX
Stock Details
BSX is Boston Scientific Corporation's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 45.52$. Average daily volumn in 3 months 6.27M. Market cap 65.76B
Stock symbol : BSX. Exchange : NYSE. Currency : USD Lastest price : 45.91$. Total volume : 7.21M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
Boston Scientific Corporation (BSX)
Last Price
45.91$Change
-0.44Volume
7.21M
| Previous Close | 46.35 |
| Open | 46.21 |
| Day Range | 45.74-46.35 |
| Bid | 0.00 x 3.2k |
| Ask | 0.00 x 1.2k |
| Volume | 7.21M |
| Average Volume | 6.27M |
| Market Cap | 65.76B |
| Beta | 0.81 |
| 52 Week Range | 34.98-47.95 |
| Trailing P/E | 111.98 |
| Foward P/E | 23.79 |
| Dividend (Yield %) | N/A |
| Ex-Dividend Date | N/A |
Financial Details
Organization
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable c... ardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Market Cap:
65.76BRevenue:
11.89BTotal Assets:
32.23BTotal Cash:
1.93B
News about "Boston Scientific Corporation"
Boston Scientific Corp. stock rises Wednesday, outperforms market
Source from : MarketWatch - 3 days ago
Shares of Boston Scientific Corp. inched 0.61% higher to $46.12 Wednesday, on what proved to be an all-around mixed trading session for the stock ...See details»
Boston Scientific Corp. stock outperforms competitors despite losses on the day
Source from : MarketWatch - 4 days ago
Shares of Boston Scientific Corp. slumped 0.02% to $45.84 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with ...See details»
Here's Why You Should Retain Boston Scientific (BSX) Now
Source from : Yahoo - 5 days ago
Boston Scientific Corporation BSX is well poised for growth in coming quarters backed by new value-added acquisitions. Robust performance of the WATCHMAN device instills investors’ optimism.See details»
Can Boston Scientific Corporation (NYSE: BSX) Still Be Hot This Week?
Source from : stocksregister - 4 days ago
Boston Scientific Corporation (NYSE:BSX) traded at $45.65 at last check on Tuesday, January 24, made a downward move of -0.43% on its previous day’s price. Looking at the stock we see that its ...See details»
BSX Boston Scientific Corporation
Source from : Seeking Alpha - 2 days ago
**NM signifies a non meaningful value. A dash signifies the data is not available.See details»
Will Boston Scientific (BSX) Beat Q4 Earnings Estimates?
Source from : Zacks.com on MSN - 9 days ago
Boston Scientific Corporation BSX is scheduled to report fourth-quarter and full-year 2022 results on Feb 1, before the opening bell. In the last reported quarter, the company’s earnings per share of ...See details»
Boston Scientific Corporation (NYSE: BSX): Is Its Value Too High Compared To Others?
Source from : stocksregister - 8 days ago
Boston Scientific Corporation (NYSE:BSX) shares, rose in value on Friday, January 20, with the stock price up by 0.34% to the previous day’s close as strong demand from buyers drove the stock to ...See details»
Is There a Dimmer Outlook Ahead for Boston Scientific Corporation (BSX)?
Source from : newsheater - 1 year ago
Boston Scientific Corporation (NYSE:BSX) went down by -1.05% from its latest closing price compared to the recent 1-year high of $47.95. The company’s stock price has collected 0.99% of gains in the ...See details»
Boston Scientific Corp. Shares Near 52-Week High - Market Mover
Source from : Nasdaq - 1 month ago
Boston Scientific Corp. (BSX) shares closed today at 1.6% below its 52 week high of $47.95, giving the company a market cap of $67B. The stock is currently up 11.1% year-to-date, up 13.9% over the ...See details»
Boston Scientific to Participate in J.P. Morgan Healthcare Conference and Announces Conference Call Discussing Fourth Quarter 2022 Results
Source from : Business Insider - 25 days ago
The word "Markets Insider". MARLBOROUGH, Mass., Jan. 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 41 st Annual J.P. Morgan Healthcare Conference on ...See details»
Boston Scientific Corp. 5.5% Pfd. Series A
Source from : Wall Street Journal - 17 days ago
Michael F. Mahoney Chairman, President & Chief Executive Officer Baxter Healthcare Ltd. (United Kingdom), Boys & Girls Club of Boston, Baxter SpA, Baxter Healthcare Pty Ltd., Boston Scientific ...See details»
Client Profile: Boston Scientific Corp
Source from : OpenSecrets.org - 8 month ago
Boston Scientific Corp Alpine Group SECOND QUARTER REPORT $50,000 Boston Scientific Corp Alpine Group THIRD QUARTER REPORT $50,000 Boston Scientific Corp Boston Scientific Corp FIRST QUARTER REPORT ...See details»
Boston Scientific Corp.
Source from : Barron's - 1 year ago
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments ...See details»
Boston Scientific Corp Pref Series A (BSX_pa)
Source from : Investing - 29 days ago
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...See details»